Market Research

MEA Duchenne Muscular Dystrophy Treatment Market - Industry Trends and Forecast to 2033

Best Price Guarantee Length Publisher Published Date SKU
from $3,500 161 Pages Data Bridge Market Research October, 2023 DAABD18360491
Best Price Guarantee
Price from $3,500
Length 161 Pages
Publisher Data Bridge Market Research
Published Date October, 2023
SKU DAABD18360491

MEA Duchenne Muscular Dystrophy Treatment Market - Industry Trends and Forecast to 2033


The Middle East and Africa duchenne muscular dystrophy treatment market is expected to reach USD 182,711.91 thousand by 2030 from USD 65,136.76 thousand in 2022, growing at a CAGR of 14.3% in the forecast period of 2023 to 2030.
Market Segmentation
Middle East and Africa Duchenne Muscular Dystrophy Treatment Market, By Treatment Type (Molecular-Based Therapies, Steroid Therapy, and Others), Therapy (Exon Skipping Approach, Mutation Suppression, and Dystrophin-Targeted Therapies), Route of Administration (Oral, Parenteral, and Others), End User (Hospitals, Specialty Clinics, Homecare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030

Overview of Middle East and Africa Duchenne Muscular Dystrophy Treatment Market Dynamics

Driver
• Increasing prevalence and impact of Duchenne Muscular Dystrophy (DMD) disease

Restraint

• High treatment cost of DMD disorder

Opportunity

• Strategic initiatives by key market players

Market Players

Some of the key market players for Middle East and Africa duchenne muscular dystrophy treatment market are:

• Sarepta Therapeutics, Inc.
• Solid Biosciences Inc.
• Capricor Therapeutics, Inc.
• Dyne Therapeutics
• BioMarin
• Stealth BioTherapeutics Inc
• Avidity Biosciences
• ReveraGen
• BioPharma, Inc.
• TAIHO PHARMACEUTICAL CO., LTD.
• Akashi RX
• ITALFARMACO S.p.
• NS Pharma, Inc.
• PTC Therapeutics.
• Pfizer Inc.
• FibroGen, Inc.
• SANTHERA PHARMACEUTICALS
• F. Hoffmann-La Roche Ltd


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Middle East And Africa Duchenne Muscular Dystrophy Treatment Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Treatment Type Segment Lifeline Curve
2.8 Market End User Coverage Grid
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel's Model
4.2 Porter's Five Forces Model
4.3 Pricing Analysis
5 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: Regulations
5.1 Regulations In U.S.
5.2 Regulattions In Europe
5.3 Regulattions In Australia
5.4 Regulations In South Africa
5.5 Regulations In Brazil 42 
6 Market Overview
6.1 Drivers
6.1.1 Increasing Prevalence And Impact Of Duchenne Muscular Dystrophy (Dmd) Disease
6.1.2 Introduction Of Novel Therapies For Dmd Disorder
6.1.3 Rising Awareness For Dmd Treatments
6.1.4 Increase In The Number Of Clinical Trials Is A Recent Trend
6.2 Restraints
6.2.1 Limited Availability Of Dmd Treatments Due To Lack Of Advance Technology
6.2.2 High Treatment Cost Of Dmd Disorder
6.3 Opportunities
6.3.1 Development Of Healthcare Infrastructure And Increasing Investment
6.3.2 Rising Patient Inclination Towards Personalized And Effective Therapies
6.3.3 Strategic Initiatives By The Key Market Players
6.3.4 Support From Patient Advocacy Groups On The Regulatory Approval Process
6.4 Challenges
6.4.1 Lack Of Standardization In Dmd Diagnosis
6.4.2 Ethical Considerations Related To Permanent Alteration Of A Patient's Genetic Code
7 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Treatment Type
7.1 Overview
7.2 Molecular-based Therapies
7.2.1 Antisense Oligonucleotide Therapy
7.2.1.1 Exondys 51
7.2.1.2 Amondys 45
7.2.1.3 Vyondys 53
7.3 Nonsense Mutation
7.3.1.1 Translarna
7.4 Steroid Therapy
7.4.1 Prednisone
7.4.2 Deflazacort
7.5 Others 62 
8 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Therapy
8.1 Overview
8.2 Exon Skipping Approach
8.2.1 Multi-exon Skipping Approach
8.2.2 Single-exon Skipping Approach
8.3 Mutation Suppression
8.4 Dystrophin-targeted Therapies
8.4.1 Gene Therapies
8.4.2 Cell Therapies
8.4.2.1 Gene Editing
8.4.2.2 Gene Addition
9 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Route Of Administration
9.1 Overview
9.2 Parenteral
9.3 Oral
9.4 Others
10 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By End User
10.1 Overview
10.2 Hospitals
10.3 Specialty Clinics
10.4 Homecare
10.5 Others
11 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Distribution Channel
11.1 Overview
11.2 Hospital Pharmacy
11.3 Retail Pharmacy
11.4 Online Pharmacy 92 
12 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Region
12.1 Middle East And Africa
12.1.1 South Africa
12.1.2 Saudi Arabia
12.1.3 U.A.E
12.1.4 Egypt
12.1.5 Israel
12.1.6 Rest Of Middle East And Africa
13 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, Company Landscape
13.1 Company Share Analysis: Middle East And Africa
14 Swot Analysis
15 Company Profiles
15.1 Sarepta Therapeutics, Inc.
15.1.1 Company Snapshot
15.1.1 Revenue Analysis
15.1.2 Company Share Analysis
15.1.3 Product Portfolio
15.1.4 Pipeline Portfolio
15.1.5 Recent Developments
15.2 F. Hoffmann-la Roche Ltd
15.2.1 Company Snapshot
15.2.2 Revenue Analysis
15.2.3 Company Share Analysis
15.2.4 Product Portfolio
15.2.5 Pipeline Portfolio
15.2.6 Recent Developments
15.3 Ptc Therapeutics.
15.3.1 Company Snapshot
15.3.2 Revenue Analysis
15.3.3 Company Share Analysis
15.3.4 Product Portfolio
15.3.5 Recent Development 135 
15.4 Pfizer Inc.
15.4.1 Company Snapshot
15.4.2 Revenue Analysis
15.4.3 Company Share Analysis
15.4.4 Pipeline Portfolio
15.4.5 Product Portfolio
15.4.6 Recent Development
15.5 Akashi Rx
15.5.1 Company Snapshot
15.5.2 Pipeline Portfolio
15.5.3 Recent Developments
15.6 Avidity Biosciences
15.6.1 Company Snapshot
15.6.2 Revenue Analysis
15.6.3 Pipeline Portfolio
15.6.4 Recent Developments
15.7 Biomarin
15.7.1 Company Snapshot
15.7.2 Revenue Analysis
15.7.3 Pipeline Portfolio
15.7.4 Recent Developments
15.8 Capricor Therapeutics, Inc.
15.8.1 Company Snapshot
15.8.2 Pipeline Portfolio
15.8.3 Recent Developments
15.9 Dyne Therapeutics
15.9.1 Company Snapshot
15.9.2 Pipeline Portfolio
15.9.3 Recent Developments
15.10 Fibrogen, Inc.
15.10.1 Company Snapshot
15.10.2 Revenue Analysis
15.10.3 Pipeline Portfolio
15.10.4 Recent Development
15.11 Italfarmaco S.P.A.
15.11.1 Company Snapshot
15.11.2 Pipeline Portfolio
15.11.3 Recent Development 149 
15.12 Ns Pharma, Inc.
15.12.1 Company Snapshot
15.12.2 Pipeline Portfolio
15.12.3 Recent Developments
15.13 Reveragen Biopharma, Inc.
15.13.1 Company Snapshot
15.13.2 Pipeline Portfolio
15.13.3 Recent Development
15.14 Santhera Pharmaceuticals
15.14.1 Company Snapshot
15.14.2 Revenue Analysis
15.14.3 Pipeline Portfolio
15.14.4 Recent Development
15.15 Taiho Pharmaceutical Co., Ltd.
15.15.1 Company Snapshot
15.15.2 Pipeline Portfolio
15.15.3 Recent Developments
15.16 Solid Biosciences Inc.
15.16.1 Company Snapshot
15.16.2 Pipeline Portfolio
15.16.3 Recent Development
15.17 Stealth Biotherapeutics Inc
15.17.1 Company Snapshot
15.17.2 Pipeline Portfolio
15.17.3 Recent Development
16 Questionnaire
17 Related Reports
List Of Tables
Table 1 List Of Prices For Approved Drugs Of The Middle East And Africa Duchenne Muscular Dystrophy Treatment Market
Table 2 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Treatment Type , 2021-2030 (Usd Thousand)
Table 3 Middle East And Africa Molecular-based Therapies In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 4 Middle East And Africa Molecular-based Therapies In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 5 Middle East And Africa Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 6 Middle East And Africa Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 7 Middle East And Africa Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 8 Middle East And Africa Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 9 Middle East And Africa Others In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 10 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 11 Middle East And Africa Exon Skipping Approach In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 12 Middle East And Africa Exon Skipping Approach In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 13 Middle East And Africa Mutation Suppression In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 14 Middle East And Africa Dystrophin-targeted Therapies In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 15 Middle East And Africa Dystrophin-targeted Therapies In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 16 Middle East And Africa Cell Therapies In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 17 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Route Of Administration , 2021-2030 (Usd Thousand)
Table 18 Middle East And Africa Parenteral In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 19 Middle East And Africa Oral In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 20 Middle East And Africa Others In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 21 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By End Users, 2021-2030 (Usd Thousand)
Table 22 Middle East And Africa Hospitals In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 23 Middle East And Africa Speciality Clinics In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 24 Middle East And Africa Homecare In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 25 Middle East And Africa Others In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 26 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 27 Middle East And Africa Hospital Pharmacy In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 28 Middle East And Africa Retail Pharmacy In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 29 Middle East And Africa Online Pharmacy In Duchenne Muscular Dystrophy Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 30 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Country, 2021-2030 (Usd Thousand)
Table 31 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 32 Middle East And Africa Molecular-based Therapies In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 33 Middle East And Africa Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 34 Middle East And Africa Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 35 Middle East And Africa Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 36 Middle East And Africa Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 37 Middle East And Africa Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 38 Middle East And Africa Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 39 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 40 Middle East And Africa Exon Skipping Approach In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 41 Middle East And Africa Dystrophin-targeted Therapies In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 42 Middle East And Africa Cell Therapies In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 43 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 44 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 45 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 46 South Africa Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 47 South Africa Molecular-based Therapies In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 48 South Africa Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 49 South Africa Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 50 South Africa Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 51 South Africa Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 52 South Africa Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 53 South Africa Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 54 South Africa Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 55 South Africa Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 56 South Africa Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 57 South Africa Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 58 South Africa Exon Skipping Approach In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 59 South Africa Dystrophin-targeted Therapies In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 60 South Africa Cell Therapies In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 61 South Africa Duchenne Muscular Dystrophy Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 62 South Africa Duchenne Muscular Dystrophy Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 63 South Africa Duchenne Muscular Dystrophy Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 64 Saudi Arabia Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 65 Saudi Arabia Molecular-based Therapies In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 66 Saudi Arabia Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 67 Saudi Arabia Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 68 Saudi Arabia Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 69 Saudi Arabia Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 70 Saudi Arabia Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 71 Saudi Arabia Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 72 Saudi Arabia Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 73 Saudi Arabia Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 74 Saudi Arabia Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 75 Saudi Arabia Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 76 Saudi Arabia Exon Skipping Approach In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 77 Saudi Arabia Dystrophin-targeted Therapies In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 78 Saudi Arabia Cell Therapies In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 79 Saudi Arabia Duchenne Muscular Dystrophy Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 80 Saudi Arabia Duchenne Muscular Dystrophy Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 81 Saudi Arabia Duchenne Muscular Dystrophy Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 82 U.A.E Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 83 U.A.E Molecular-based Therapies In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 84 U.A.E Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 85 U.A.E Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 86 U.A.E Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 87 U.A.E Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 88 U.A.E Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 89 U.A.E Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 90 U.A.E Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 91 U.A.E Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 92 U.A.E Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 93 U.A.E Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 94 U.A.E Exon Skipping Approach In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 95 U.A.E Dystrophin-targeted Therapies In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 96 U.A.E Cell Therapies In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 97 U.A.E Duchenne Muscular Dystrophy Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 98 U.A.E Duchenne Muscular Dystrophy Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 99 U.A.E Duchenne Muscular Dystrophy Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 100 Egypt Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 101 Egypt Molecular-based Therapies In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 102 Egypt Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 103 Egypt Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 104 Egypt Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 105 Egypt Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 106 Egypt Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 107 Egypt Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 108 Egypt Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 109 Egypt Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 110 Egypt Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 111 Egypt Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 112 Egypt Exon Skipping Approach In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 113 Egypt Dystrophin-targeted Therapies In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 114 Egypt Cell Therapies In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 115 Egypt Duchenne Muscular Dystrophy Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 116 Egypt Duchenne Muscular Dystrophy Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 117 Egypt Duchenne Muscular Dystrophy Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 118 Israel Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 119 Israel Molecular-based Therapies In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 120 Israel Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 121 Israel Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 122 Israel Antisense Oligonucleotide Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 123 Israel Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 124 Israel Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 125 Israel Nonsense Mutation In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 126 Israel Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 127 Israel Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 128 Israel Steroid Therapy In Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 129 Israel Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 130 Israel Exon Skipping Approach In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 131 Israel Dystrophin-targeted Therapies In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 132 Israel Cell Therapies In Duchenne Muscular Dystrophy Treatment Market, By Therapy, 2021-2030 (Usd Thousand)
Table 133 Israel Duchenne Muscular Dystrophy Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 134 Israel Duchenne Muscular Dystrophy Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 135 Israel Duchenne Muscular Dystrophy Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 136 Rest Of Middle East And Africa Duchenne Muscular Dystrophy Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
List Of Figures
Figure 1 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: Segmentation
Figure 2 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: Data Triangulation
Figure 3 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: Droc Analysis
Figure 4 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: Middle East And Africa Vs Regional Market Analysis
Figure 5 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: Company Research Analysis
Figure 6 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: Interview Demographics
Figure 7 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: Market End User Coverage Grid
Figure 8 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: Dbmr Market Position Grid
Figure 9 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: Vendor Share Analysis
Figure 10 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: Segmentation
Figure 11 The Rising Prevalence And Impact Of Duchenne Muscular Dystrophy (Dmd) And Introduction Of Novel Therapies For Dmd Disorder Are Expected To Drive The Growth Of The Middle East And Africa Duchenne Muscular Dystrophy Treatment Market From 2023 To 2030
Figure 12 Molecular-based Therapies Segment Is Expected To Account For The Largest Share Of The Middle East And Africa Duchenne Muscular Dystrophy Treatment Market In 2023 And 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Middle East And Africa Duchenne Muscular Dystrophy Treatment Market
Figure 14 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Treatment Type , 2022
Figure 15 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Treatment Type, 2023-2030 (Usd Thousand)
Figure 16 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Treatment Type , Cagr (2023-2030)
Figure 17 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Treatment Type, Lifeline Curve
Figure 18 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Therapy, 2022
Figure 19 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Therapy, 2023-2030 (Usd Thousand)
Figure 20 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Therapy, Cagr (2023-2030)
Figure 21 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Therapy, Lifeline Curve
Figure 22 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Route Of Administration, 2022
Figure 23 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Route Of Administration, 2023-2030 (Usd Thousand)
Figure 24 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Route Of Administration, Cagr (2023-2030)
Figure 25 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Route Of Administration, Lifeline Curve
Figure 26 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By End User, 2022
Figure 27 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By End User, 2023-2030 (Usd Thousand)
Figure 28 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By End User, Cagr (2023-2030)
Figure 29 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By End User, Lifeline Curve
Figure 30 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Distribution Channel, 2022
Figure 31 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand)
Figure 32 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Distribution Channel, Cagr (2023-2030)
Figure 33 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: By Distribution Channel, Lifeline Curve
Figure 34 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market Snapshot
Figure 35 Middle East And Africa Duchenne Muscular Dystrophy Treatment Market: Company Share 2022 (%)

$3,500
$4,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings